Quick Answer
PDS Biotechnology Corp reported Earnings Per Share Diluted of $0.74 (loss) per share for the year ending 2025.
- PDS Biotechnology Corp showed an increase of +28.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from PDS Biotechnology Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $0.39 (loss) per share | Q2 2020: $0.19 (loss) per share | Q3 2020: $0.21 (loss) per share | Q1 2021: $0.14 (loss) per share | Q2 2021: $0.03 (loss) per share | Q3 2021: $0.24 (loss) per share | Q1 2022: $0.32 (loss) per share | Q2 2022: $0.20 (loss) per share | Q3 2022: $0.26 (loss) per share | Q1 2023: $0.32 (loss) per share | Q2 2023: $0.37 (loss) per share | Q3 2023: $0.35 (loss) per share | Q1 2024: $0.30 (loss) per share | Q2 2024: $0.23 (loss) per share | Q3 2024: $0.29 (loss) per share | Q1 2025: $0.21 (loss) per share | Q2 2025: $0.21 (loss) per share | Q3 2025: $0.19 (loss) per share.
- Over the full 6 years of available data (2020 to 2025), PDS Biotechnology Corp's Earnings Per Share Diluted has grown by 16.9%.
- Historical annual values: Fiscal year 2025: $0.74 (loss) per share | Fiscal year 2024: $1.03 (loss) per share | Fiscal year 2023: $1.39 (loss) per share | Fiscal year 2022: $1.43 (loss) per share | Fiscal year 2021: $0.66 (loss) per share | Fiscal year 2020: $0.89 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: